MARRONE BIO INNOVATIONS INC. Financing Cash Flow
MARRONE BIO INNOVATIONS INC. reported Financing Cash Flow of -$1.67 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-05-13
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was -$1.67M, a 118.59% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $8.16M, a 44.44% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was -$1.75M.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was $213.00K, a 91.12% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) financing activities for fiscal 2021 was $15.59M, a 43.00% decline from fiscal 2020.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) financing activities for fiscal 2020 was $27.34M, a 69.18% increase from fiscal 2019.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) financing activities for fiscal 2019 was $16.16M, a 56.26% decline from fiscal 2018.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) financing activities for fiscal 2018 was $36.95M, a 205.65% increase from fiscal 2017.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$1.67M 10-Q · filed 2022-05-13 | $6.49M derived: sum of 2 quarters · filed 2022-05-13 | $4.74M derived: sum of 3 quarters · filed 2022-05-13 | $4.95M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $8.16M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $6.41M derived: sum of 2 quarters · filed 2022-05-09 | $6.62M derived: sum of 3 quarters · filed 2022-05-09 | $15.59M 10-K/A · filed 2022-05-09 |
| 2021-09-30 | -$1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.54M derived: sum of 2 quarters · filed 2021-11-10 | $7.43M 10-Q · filed 2021-11-10 | $22.11M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $9.18M 10-Q · filed 2021-08-16 | $23.86M derived: sum of 3 quarters · filed 2022-05-13 | $23.29M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $8.97M 10-Q · filed 2022-05-13 | $23.65M derived: sum of 2 quarters · filed 2022-05-13 | $23.08M derived: sum of 3 quarters · filed 2022-05-13 | $25.48M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $14.68M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $14.11M derived: sum of 2 quarters · filed 2022-05-09 | $16.51M derived: sum of 3 quarters · filed 2022-05-09 | $27.34M 10-K/A · filed 2022-05-09 |
| 2020-09-30 | -$567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.83M derived: sum of 2 quarters · filed 2021-11-10 | $12.66M 10-Q · filed 2021-11-10 | $16.14M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $13.23M 10-Q · filed 2021-08-16 | $16.71M derived: sum of 3 quarters · filed 2021-08-16 | $27.31M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $10.83M 10-Q · filed 2021-05-13 | $14.31M derived: sum of 2 quarters · filed 2021-05-13 | $24.91M derived: sum of 3 quarters · filed 2021-05-13 | $23.86M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $14.08M derived: sum of 2 quarters · filed 2021-03-23 | $13.03M derived: sum of 3 quarters · filed 2021-03-23 | $16.16M 10-K · filed 2021-03-23 |
| 2019-09-30 | $10.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $9.55M derived: sum of 2 quarters · filed 2020-11-09 | $12.68M 10-Q · filed 2020-11-09 | $13.03M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.08M 10-Q · filed 2020-08-10 | $2.43M derived: sum of 3 quarters · filed 2020-08-10 | $1.59M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $3.13M 10-Q · filed 2020-05-11 | $3.48M derived: sum of 2 quarters · filed 2020-05-11 | $2.63M derived: sum of 3 quarters · filed 2020-05-11 | $16.00M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$498.00K derived: sum of 2 quarters · filed 2020-03-16 | $12.87M derived: sum of 3 quarters · filed 2020-03-16 | $36.95M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$844.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | $12.53M derived: sum of 2 quarters · filed 2019-11-19 | $36.61M 10-Q · filed 2019-11-19 | $40.27M derived: sum of 4 quarters · filed 2019-11-19 |
| 2018-06-30 | $13.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $37.45M 10-Q · filed 2019-08-09 | $41.11M derived: sum of 3 quarters · filed 2019-08-09 | $38.92M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $24.08M 10-Q · filed 2019-05-10 | $27.74M derived: sum of 2 quarters · filed 2019-05-10 | $25.55M derived: sum of 3 quarters · filed 2019-05-10 | |
| 2017-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $1.47M derived: sum of 2 quarters · filed 2019-03-29 | $12.09M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $8.43M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $10.62M 10-Q · filed 2018-08-14 | |||
| 2014-03-31 | $765.00K 10-Q · filed 2014-05-15 | $801.00K derived: sum of 2 quarters · filed 2014-05-15 | $56.92M derived: sum of 3 quarters · filed 2014-05-15 | $67.01M derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | $56.16M derived: sum of 2 quarters · filed 2014-03-25 | $66.24M derived: sum of 3 quarters · filed 2014-03-25 | $66.13M 10-K · filed 2014-03-25 |
| 2013-09-30 | $56.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $66.20M derived: sum of 2 quarters · filed 2013-11-08 | $66.10M 10-Q · filed 2013-11-08 | $79.93M derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-06-30 | $10.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-09-13 | $9.98M 10-Q · filed 2013-09-13 | $23.81M derived: sum of 3 quarters · filed 2014-05-15 | $23.36M derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-03-31 | -$108.00K 10-Q · filed 2014-05-15 | $13.72M derived: sum of 2 quarters · filed 2014-05-15 | $13.27M derived: sum of 3 quarters · filed 2014-05-15 | |
| 2012-12-31 | $13.83M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | $13.38M derived: sum of 2 quarters · filed 2014-03-25 | $30.97M 10-K · filed 2014-03-25 | |
| 2012-09-30 | -$454.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $17.14M 10-Q · filed 2013-11-08 | ||
| 2012-06-30 | $17.60M 10-Q · filed 2013-09-13 | |||
| 2011-12-31 | $12.78M 10-K · filed 2014-03-25 |